Parkinson's Research (Partners Investing in Parkinson Research)
The challenge
Parkinson’s disease affects more than 100,000 Canadians,
including more than 8,000 in the Ottawa area alone. And that number
is expected to double by the year 2050. More research is needed
to better understand and treat this devastating disease.
The solution
A group of investment advisors from the Ottawa financial community
formed Partners Investing in Parkinson Research (PIPR). Co-chaired
by Richard Shantz and Andrew Frank of RBC Dominion Securities, PIPR
is seeking support from friends, colleagues and the entire community
to raise funds to help researchers discover better treatments for
patients with Parkinson’s.
PIPR has set a goal of raising $1,000,000. Since 2009, PIPR has
raised more than $500,000 for Parkinson’s research. All funds
raised by this dedicated group go directly to the Parkinson
Research Consortium, which is working on a number of innovative
treatment strategies, such as the development of new drug treatments
and targeted gene therapy that could help stop the progression of
this debilitating disease.
How you can help
You can support the PIPR team during the Ottawa Race Weekend (May
26 and 27, 2012). Members of the team will participate in the Run
for a Reason Challenge and raise funds for this important initiative.
You can also support Parkinson’s research by making a donation
directly to the Foundation. You can donate
online, download our donation form
or call us at 613-761-4295.
For more information, please contact Christine Wheeler, Development
Officer, at 613-798-5555, ext. 19818, or cwheeler@ottawahospital.on.ca.
|
